Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 28, 2018 - Issue 10
Submit an article Journal homepage
176
Views
1
CrossRef citations to date
0
Altmetric
Patent Evaluation

Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist: a patent evaluation of CA2958110 and IN6616DEN2012

Andrea AngeliNEUROFARBA Dept., Sezione di Scienze Farmaceutiche, University of Florence, Florence, ItalyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-1470-7192View further author information
ORCID Icon &
Claudiu T. SupuranNEUROFARBA Dept., Sezione di Scienze Farmaceutiche, University of Florence, Florence, ItalyView further author information
Pages 723-727 | Received 03 Apr 2018, Accepted 03 Jul 2018, Published online: 16 Jul 2018

References

  • Cowie MR. Sleep apnea: state of the art. Trends Cardiovasc Med. 2017;27(4):280–289.
  • Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394.
  • Banno K, Kryger MH. Sleep apnea: clinical investigations in humans. Sleep Med. 2007;8(4):400–426.
  • Floras JS. Sleep apnea and cardiovascular risk. J Cardiol. 2014;63(1):3–8.
  • Floras JS. Hypertension and Sleep Apnea. Can J Cardiol. 2015;31(7):889–897.
  • Javaheri S, Javaheri S, Javaheri A. Sleep apnea, heart failure, and pulmonary hypertension. Curr Heart Fail Rep. 2013;10(4):315–320.
  • Grote L, Hedner J, Grunstein R, et al. Eur Respir J. 2000;16(5):921–927.
  • Supuran CT. Structure and function of carbonic anhydrases. Biochem J. 2016 15; 473(14):2023–2032.
  • Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem. 2016;31(3):345–360.
  • Winum JY, Supuran CT. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 2015;30(2):321–324.
  • Supuran CT. Carbonic anhydrase inhibitors: an editorial. Expert Opin Ther Pat. 2013;23(6):677–679.
  • Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008;7(2):168–181.
  • Scozzafava A, Supuran CT. Glaucoma and the applications of carbonic anhydrase inhibitors. Subcell Biochem. 2014;75:349–359.
  • Supuran CT. Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol. 2016;12(4):423–431.
  • Carone L, Oxberry SG, Twycross R, et al. Furosemide. J Pain Symptom Manage. 2016;52(1):144–150.
  • Carta F, Scozzafava A, Supuran CT. Sulfonamides: a patent review (2008–2012). Expert Opin Ther Pat. 2012;22:747–758.
  • Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov. 2017;12(1):61–88.
  • Di Fiore A, Pedone C, D’Ambrosio K, et al. Carbonic anhydrase inhibitors: valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II “selective” inhibitor celecoxib. Bioorg Med Chem Lett. 2006;16(2):437–442.
  • Guichard JL, Clark D 3rd, Calhoun DA, et al. Aldosterone receptor antagonists: current perspectives and therapies. Vasc Health Risk Manag. 2013;9:321–331.
  • Funder JW. Minireview: aldosterone and mineralocorticoid receptors: past, present, and future. Endocrinology. 2010;151(11):5098–5102.
  • Winslow DH, Bowden CH, DiDonato KP, et al. A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults. SLEEP. 2012;35(11):1529–1539.
  • Brownell K. The LEARN program for weight management. Dallas: The Life Style Company; 2000.
  • Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–545.
  • Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992;15(4):376–381.
  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
  • Maren TH. Carbonic anhydrase: chemistry, physiology, and inhibition. Physiological Reviews. 1967;47:595–781.
  • Supuran CT. Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites. 2017;7(3):48.
  • Supuran CT. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics? Front Pharmacol. 2011;2:34.
  • Supuran CT. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. Expert Opin Emerg Drugs. 2012;17(1):11–15.
  • Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens. 2012;26(5):281–287.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.